The role of photodynamic therapy in overcoming cancer drug resistance

Photochemical and Photobiological Sciences

Volumn 14, Issue 8, 2015, Pages 1476-1491

  Spring, Bryan Q ^a   Rizvi, Imran ^a,b   Xu, Nan ^a,c   Hasan, Tayyaba ^a,d  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c TONGJI UNIVERSITY   (China)

^d HARVARD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHOTOSENSITIZING AGENT;

ANIMAL; DRUG RESISTANCE; HUMAN; METABOLISM; NEOPLASMS; PATHOLOGY; PHOTOCHEMOTHERAPY; PROCEDURES;

ANIMALS; DRUG RESISTANCE, NEOPLASM; HUMANS; NEOPLASMS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS;

EID: 84938329353     PISSN: 1474905X     EISSN: 14749092     Source Type: Journal    
DOI: 10.1039/c4pp00495g     Document Type: Review

References (125)

1. R. C. Bast B. Hennessy G. B. Mills The biology of ovarian cancer new opportunities for translation Nat. Rev. Cancer 2009 9 415 428
2. M. T. Milano et al., Patterns and timing of recurrence after temozolomide-based chemoradiation for glioblastoma Int. J. Radiat. Oncol., Biol., Phys. 2010 78 1147 1155
3. C. Holohan S. Van Schaeybroeck D. B. Longley P. G. Johnston Cancer drug resistance an evolving paradigm Nat. Rev. Cancer 2013 13 714 726
4. D. Hanahan R. A. Weinberg Hallmarks of Cancer: The Next Generation Cell 2011 144 646 674
5. J. P. Thiery H. Acloque R. Y. Huang M. A. Nieto Epithelial-mesenchymal transitions in development and disease Cell 2009 139 871 890
6. C. T. Jordan M. L. Guzman M. Noble Cancer Stem Cells N. Engl. J. Med. 2006 355 1253 1261
7. S. Bao et al., Glioma stem cells promote radioresistance by preferential activation of the DNA damage response Nature 2006 444 756 760
8. I. Rizvi et al., Flow induces epithelial-mesenchymal transition, cellular heterogeneity and biomarker modulation in 3D ovarian cancer nodules Proc. Natl. Acad. Sci. U. S. A. 2013 110 E1974 E1983
9. R. Kalluri R. A. Weinberg The basics of epithelial-mesenchymal transition J. Clin. Invest. 2009 119 1420 1428
10. B. Sennino et al., Suppression of tumor invasion and metastasis by concurrent inhibition of c-Met and VEGF signaling in pancreatic neuroendocrine tumors Cancer Discovery 2012 2 270 287
11. S. Thomson et al., Epithelial to mesenchymal transition is a determinant of sensitivity of non-small-cell lung carcinoma cell lines and xenografts to epidermal growth factor receptor inhibition Cancer Res. 2005 65 9455 9462
12. A. M. Haslehurst et al., EMT transcription factors snail and slug directly contribute to cisplatin resistance in ovarian cancer BMC Cancer 2012 2 91
13. M. Izumiya et al., Chemoresistance is associated with cancer stem cell-like properties and epithelial-to-mesenchymal transition in pancreatic cancer cells Anticancer Res. 2012 32 3847 3853
14. F. Du et al., Acquisition of paclitaxel resistance via PI3K-dependent epithelial-mesenchymal transition in A2780 human ovarian cancer cells Oncol. Rep. 2013 30 1113 1118
15. S. A. Mani et al., The epithelial-mesenchymal transition generates cells with properties of stem cells Cell 2008 133 704 715
16. M. Pàez-Ribes et al., Antiangiogenic Therapy Elicits Malignant Progression of Tumors to Increased Local Invasion and Distant Metastasis Cancer Cell 2009 15 220 231
17. S. Pennacchietti et al., Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene Cancer Cell 2003 3 347 361
18. B. Sennino D. M. McDonald Controlling escape from angiogenesis inhibitors Nat. Rev. Cancer 2012 12 699 709
19. R. K. Jain Antiangiogenesis Strategies Revisited: From Starving Tumors to Alleviating Hypoxia Cancer Cell 2014 26 605 622
20. D. E. J. G. J. Dolmans D. Fukumura R. K. Jain TIMELINE: Photodynamic therapy for cancer Nat. Rev. Cancer 2003 3 380 387
21. C. Schweitzer R. Schmidt Physical mechanisms of generation and deactivation of singlet oxygen Chem. Rev. 2003 1685 1757
22. J. F. Lovell T. W. B. Liu J. Chen G. Zheng Activatable photosensitizers for imaging and therapy Chem. Rev. 2010 110 2839 2857
23. J. P. Celli et al., Imaging and photodynamic therapy: mechanisms, monitoring, and optimization Chem. Rev. 2010 110 2795 2838
24. B. Spring et al., Selective treatment and monitoring of disseminated cancer micrometastases in vivo using dual-function, activatable immunoconjugates Proc. Natl. Acad. Sci. U. S. A. 2014 111 E933 E942
25. M. L. Agarwal et al., Photodynamic therapy induces rapid cell death by apoptosis in L5178Y mouse lymphoma cells Cancer Res. 1991 51 5993 5996
26. D. Kessel Death pathways associated with photodynamic therapy Med. Laser Appl. 2006 21 219 224
27. R. Rahmanzadeh et al., Ki-67 as a molecular target for therapy in an in vitro three-dimensional model for ovarian cancer Cancer Res. 2010 70 9234 9242
28. Q. Wan L. Liu D. Xing Q. Chen Bid Is Required in NPe6-PDT-induced Apoptosis Photochem. Photobiol. 2007 84 250 257
29. J. J. Reiners P. Agostinis K. Berg N. L. Oleinick D. Kessel Assessing autophagy in the context of photodynamic therapy Autophagy 2010 6 7 18
30. J. Lindsay M. D. Esposti A. P. Gilmore Bcl-2 proteins and mitochondria-specificity in membrane targeting for death Biochim. Biophys. Acta 2011 1813 532 539
31. B. Schellenberg et al., Bax exists in a dynamic equilibrium between the cytosol and mitochondria to control apoptotic priming Mol. Cell 2013 49 959 971
32. D. Kessel Y. Luo Photodynamic therapy: A mitochondrial inducer of apoptosis Cell Death Differ. 1999 6 28 35
33. J. C. Reed et al., BCL-2 family proteins: Regulators of cell death involved in the pathogenesis of cancer and resistance to therapy J. Cell. Biochem. 1996 60 23 32
34. A. Villanueva J. C. Stockert M. Cañete P. Acedo A new protocol in photodynamic therapy: enhanced tumour cell death by combining two different photosensitizers Photochem. Photobiol. Sci. 2010 9 295 297
35. P. Acedo J. C. Stockert M. Canete A. Villanueva Two combined photosensitizers: a goal for more effective photodynamic therapy of cancer Cell Death Dis. 2014 5 e1122
36. X. Schneider-Yin et al., Hypericin and 5-aminolevulinic acid-induced protoporphyrin IX induce enhanced phototoxicity in human endometrial cancer cells with non-coherent white light Photodiagn. Photodyn. Ther. 2009 6 12 18
37. E. B. Gyenge et al., Photodynamic mechanisms induced by a combination of hypericin and a chlorin based-photosensitizer in head and neck squamous cell carcinoma cells Photochem. Photobiol. 2013 89 150 162
38. D. Kessel J. J. Reiners Enhanced Efficacy of Photodynamic Therapy via a Sequential Targeting Protocol Photochem. Photobiol. 2014 90 889 895
39. L. Cincotta D. Szeto E. Lampros T. Hasan A. H. Cincotta Benzophenothiazine and Benzoporphyrin Derivative Combination Phototherapy Effectively Eradicates Large Murine Sarcomas Photochem. Photobiol. 1996 63 229 237
40. M. M. Gottesman T. Fojo S. E. Bates Multidrug resistance in cancer: role of ATP|[ndash]|dependent transporters Nat. Rev. Cancer 2002 2 48 58
41. V. Goler-Baron Y. G. Assaraf Overcoming multidrug resistance via photodestruction of ABCG2-rich extracellular vesicles sequestering photosensitive chemotherapeutics PLoS One 2012 7 e35487
42. S. O. Gollnick L. Vaughan B. W. Henderson Generation of effective antitumor vaccines using photodynamic therapy Cancer Res. 2002 62 1604 1608
43. M. Shams B. Owczarczak P. Manderscheid-Kern D. A. Bellnier S. O. Gollnick Development of photodynamic therapy regimens that control primary tumor growth and inhibit secondary disease Cancer Immunol. Immunother. 2015 64 287 297
44. A. P. Castano P. Mroz M. R. Hamblin Photodynamic therapy and anti-tumour immunity Nat. Rev. Cancer 2006 6 535 545
45. B. Chen B. W. Pogue P. J. Hoopes T. Hasan Combining vascular and cellular targeting regimens enhances the efficacy of photodynamic therapy Int. J. Radiat. Oncol., Biol., Phys. 2005 61 1216 1226
46. V. H. Fingar et al., Analysis of acute vascular damage after photodynamic therapy using benzoporphyrin derivative (BPD) Br. J. Cancer 1999 79 1702 1708
47. K. Kurohane et al., Photodynamic therapy targeted to tumor-induced angiogenic vessels Cancer Lett. 2001 167 49 56
48. U. Schmidt-Erfurth T. Hasan Mechanisms of Action of Photodynamic Therapy with Verteporfin for the Treatment of Age-Related Macular Degeneration Surv. Ophthalmol. 2000 45 195 214
49. J. W. Snyder W. R. Greco D. A. Bellnier L. Vaughan B. W. Henderson Photodynamic therapy: a means to enhanced drug delivery to tumors Cancer Res. 2003 63 8126 8131
50. B. Chen B. W. Pogue J. M. Luna R. L. Hardman P. J. Hoopes Tumor vascular permeabilization by vascular-targeting photosensitization: effects, mechanism, and therapeutic implications Clin. Cancer Res. 2006 12 917 923
51. M. Gil et al., Photodynamic therapy augments the efficacy of oncolytic vaccinia virus against primary and metastatic tumours in mice Br. J. Cancer 2011 105 1512 1521
52. K. Sano T. Nakajima P. L. Choyke H. Kobayashi Markedly enhanced permeability and retention effects induced by photo-immunotherapy of tumors ACS Nano 2013 7 717 724
53. O.-J. Norum P. K. Selbo A. Weyergang K.-E. Giercksky K. Berg Photochemical internalization (PCI) in cancer therapy: From bench towards bedside medicine J. Photochem. Photobiol., B 2009 96 83 92
54. P. K. Selbo et al., Strongly amphiphilic photosensitizers are not substrates of the cancer stem cell marker ABCG2 and provides specific and efficient light-triggered drug delivery of an EGFR-targeted cytotoxic drug J. Controlled Release 2012 159 197 203
55. M. Bostad et al., Photochemical internalization (PCI) of immunotoxins targeting CD133 is specific and highly potent at femtomolar levels in cells with cancer stem cell properties J. Controlled Release 2013 168 317 326
56. M. Bostad et al., Light-triggered, efficient cytosolic release of IM7-saporin targeting the putative cancer stem cell marker CD44 by photochemical internalization Mol. Pharm. 2014 11 2764 2776
57. A. Casas G. Di Venosa A. Batlle Mechanisms of resistance to photodynamic therapy Curr. Med. Chem. 2011 18 2486 2515
58. C. L. Evans et al., Killing hypoxic cell populations in a 3D tumor model with EtNBS-PDT PLoS One 2011 6 e23434
59. M. C. Luna C. J. Gomer Isolation and initial characterization of mouse tumor cells resistant to porphyrin-mediated photodynamic therapy Cancer Res. 1991 51 4243 4249
60. B. C. Wilson M. Olivo G. Singh Subcellular Localization of Photofrin and Aminolevulinic Acid and Photodynamic Cross-Resistance in Vitro in Radiation-Induced Fibrosarcoma Cells Sensitive or Resistant to Photofrin-Mediated Photodynamic Therapy Photochem. Photobiol. 1997 65 166 176
61. R. A. Moorehead S. G. Armstrong B. C. Wilson G. Singh Cross-Resistance to Cisplatin in Cells Resistant to Photofrin-mediated Photodynamic Therapy Cancer Res. 1994 54 2556 2559
62. A. Casas et al., Tumor cell lines resistant to ALA-mediated photodynamic therapy and possible tools to target surviving cells Int. J. Oncol. 2006 29 397 405
63. Z. Duan D. E. Lamendola Y. Duan R. Z. Yusuf M. V. Seiden Description of paclitaxel resistance-associated genes in ovarian and breast cancer cell lines Cancer Chemother. Pharmacol. 2004 55 277 285
64. D. Roberts et al., Identification of genes associated with platinum drug sensitivity and resistance in human ovarian cancer cells Br. J. Cancer 2005 92 1149 1158
65. R. W. Robey K. Steadman O. Polgar S. E. Bates ABCG2-mediated transport of photosensitizers: potential impact on photodynamic therapy Cancer Biol. Ther. 2005 4 187 194
66. W. Liu et al., The Tyrosine Kinase Inhibitor Imatinib Mesylate Enhances the Efficacy of Photodynamic Therapy by Inhibiting ABCG2 Clin. Cancer Res. 2007 13 2463 2470
67. J. Morgan J. D. Jackson X. Zheng S. K. Pandey R. K. Pandey Substrate affinity of photosensitizers derived from chlorophyll-a: the ABCG2 transporter affects the phototoxic response of side population stem cell-like cancer cells to photodynamic therapy Mol. Pharm. 2010 7 1789 1804
68. C.-H. Yu C.-C. Yu Photodynamic therapy with 5-aminolevulinic acid (ALA) impairs tumor initiating and chemo-resistance property in head and neck cancer-derived cancer stem cells PLoS One 2014 9 e87129
69. T. A. Yap C. P. Carden S. B. Kaye Beyond chemotherapy: targeted therapies in ovarian cancer Nat. Rev. Cancer 2009 9 167 181
70. T. Conroy et al., FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer N. Engl. J. Med. 2011 364 1817 1825
71. M. G. del Carmen et al., Synergism of epidermal growth factor receptor-targeted immunotherapy with photodynamic treatment of ovarian cancer in vivo J. Natl. Cancer Inst. 2005 97 1516 1524
72. I. Rizvi et al., Synergistic enhancement of carboplatin efficacy with photodynamic therapy in a three-dimensional model for micrometastatic ovarian cancer Cancer Res. 2010 70 9319 9328
73. L. R. Duska M. R. Hamblin J. L. Miller T. Hasan Combination photoimmunotherapy and cisplatin: effects on human ovarian cancer ex vivo J. Natl. Cancer Inst. 1999 91 1557 1563
74. M. F. Zuluaga N. Lange Combination of photodynamic therapy with anti-cancer agents Curr Med Chem. 2008 15 1655 1673
75. M. Y. Nahabedian R. A. Cohen M. F. Contino et al. Combination cytotoxic chemotherapy with cisplatin or doxorubicin and photodynamic therapy in murine tumors J. Natl. Cancer Inst. 1988 80 739 743
76. G. Canti A. Nicolin R. Cubeddu P. Taroni G. Bandieramonte G. Valentini Antitumor efficacy of the combination of photodynamic therapy and chemotherapy in murine tumors Cancer Lett. 1998 125 39 44
77. C. M. Peterson J. M. Lu Y. Sun et al. Combination chemotherapy and photodynamic therapy with N-(2-hydroxypropyl) methacrylamide copolymer-bound anticancer drugs inhibit human ovarian carcinoma heterotransplanted in nude mice Cancer Res. 1996 56 3980 3985
78. J. P. Celli N. Solban A. Liang S. P. Pereira T. Hasan Verteporfin-based photodynamic therapy overcomes gemcitabine insensitivity in a panel of pancreatic cancer cell lines Lasers Surg. Med. 2011 43 565 574
79. B. A. Goff M. Bamberg T. Hasan Photoimmunotherapy of human ovarian carcinoma cells ex vivo Cancer Res. 1991 51 4762 4767
80. J. M. Stommel et al., Coactivation of Receptor Tyrosine Kinases Affects the Response of Tumor Cells to Targeted Therapies Science 2007 318 287 290
81. A. D. Rhim et al., Stromal elements act to restrain, rather than support, pancreatic ductal adenocarcinoma Cancer Cell 2014 25 735 747
82. B. C. Özdemir et al., Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival Cancer Cell 2014 25 719 734
83. M. Upreti et al., Tumor-Endothelial Cell Three-dimensional Spheroids: New Aspects to Enhance Radiation and Drug Therapeutics Transl. Oncol. 2011 4 365 376
84. J. W. Franses A. B. Baker V. C. Chitalia E. R. Edelman Stromal endothelial cells directly influence cancer progression Sci. Transl. Med. 2011 3 665
85. S. K. Chang I. Rizvi N. Solban In vivo optical molecular imaging of vascular endothelial growth factor for monitoring cancer treatment Clin. Cancer Res. 2008 14 4146 4153
86. C. J. Gomer et al., Photodynamic Therapy-mediated Oxidative Stress Can Induce Expression of Heat Shock Proteins Cancer Res. 1996 56 2355 2360
87. A. Ferrario et al., Antiangiogenic treatment enhances photodynamic therapy responsiveness in a mouse mammary carcinoma Cancer Res. 2000 60 4066 4069
88. A. Ferrario N. Rucker S. Wong M. Luna C. J. Gomer Survivin, a Member of the Inhibitor of Apoptosis Family, Is Induced by Photodynamic Therapy and Is a Target for Improving Treatment Response Cancer Res. 2007 67 4989 4995
89. D. L. Wheeler E. F. Dunn P. M. Harari Understanding resistance to EGFR inhibitors-impact on future treatment strategies Nat. Rev. Clin. Oncol. 2010 7 493 507
90. Y. Gilaberte et al., Cellular intrinsic factors involved in the resistance of squamous cell carcinoma to photodynamic therapy J. Invest. Dermatol. 2014 134 2428 2437
91. N. Solban et al., Mechanistic investigation and implications of photodynamic therapy induction of vascular endothelial growth factor in prostate cancer Cancer Res. 2006 66 5633 5640
92. P. Nowak-Sliwinska J. R. van Beijnum M. van Berkel H. van den Bergh A. W. Griffioen Vascular regrowth following photodynamic therapy in the chicken embryo chorioallantoic membrane Angiogenesis 2010 13 281 292
93. A. Weiss et al., Low-dose angiostatic tyrosine kinase inhibitors improve photodynamic therapy for cancer: lack of vascular normalization J. Cell. Mol. Med. 2014 18 480 491
94. P. Nowak-Sliwinska et al., Angiostatic kinase inhibitors to sustain photodynamic angio-occlusion J. Cell. Mol. Med. 2012 16 1553 1562
95. D. H. Gorski et al., Blockade of the vascular endothelial growth factor stress response increases the antitumor effects of ionizing radiation Cancer Res. 1999 59 3374 3378
96. J. Tran et al., A role for survivin in chemoresistance of endothelial cells mediated by VEGF Proc. Natl. Acad. Sci. U. S. A. 2002 99 4349 4354
97. C. Justinger et al., Increased growth factor expression after hepatic and pancreatic resection Oncol. Rep. 2008 20 1527 1531
98. B. Kosharskyy et al., A mechanism-based combination therapy reduces local tumor growth and metastasis in an orthotopic model of prostate cancer Cancer Res. 2006 66 10953 10958
99. H.-C. Huang T. Hasan The 'Nano' World in Photodynamic Therapy Aust. J. Nanomed. Nanotechnol. 2014 2 4
100. J. F. Lovell et al., Porphysome nanovesicles generated by porphyrin bilayers for use as multimodal biophotonic contrast agents Nat. Mater. 2011 10 324 332
101. K. A. Carter et al., Porphyrin-phospholipid liposomes permeabilized by near-infrared light Nat. Commun. 2014 5 3546
102. T. Nomoto et al., Three-layered polyplex micelle as a multifunctional nanocarrier platform for light-induced systemic gene transfer Nat. Commun. 2014 5 3545
103. T. R. Wilson et al., Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitors Nature 2012 487 505 509
104. C. Hage et al., The novel c-Met inhibitor cabozantinib overcomes gemcitabine resistance and stem cell signaling in pancreatic cancer Cell Death Dis. 2013 4 e627
105. E. Gherardi W. Birchmeier C. Birchmeier G. Vande-Woude Targeting MET in cancer: rationale and progress Nat. Rev. Cancer 2012 12 89 103
106. S. Peters A. A. Adjei MET: a promising anticancer therapeutic target Nat. Rev. Clin. Oncol. 2012 9 314 326
107. B. Sennino T. Ishiguro-Oonuma B. J. Schriver J. G. Christensen D. M. McDonald Inhibition of c-Met reduces lymphatic metastasis in RIP-Tag2 transgenic mice Cancer Res. 2013 73 3692 3703
108. L. Z. Zheng et al., Abstract A127: Combination therapy targeting EGFR/MET crosstalk using nanotechnology improves photodynamic therapy treatment of pancreatic cancer Mol. Cancer Ther. 2009 8 A127 A127
109. M. Bernstein and M. S. Berger, Neuro-oncology: The Essentials, Thieme, 2011
110. M. T. Huggett et al., Phase I/II study of verteporfin photodynamic therapy in locally advanced pancreatic cancer Br. J. Cancer 2014 110 1698 1704
111. M. S. Eljamel C. Goodman H. Moseley ALA and Photofrin fluorescence-guided resection and repetitive PDT in glioblastoma multiforme: a single centre Phase III randomised controlled trial Lasers Med. Sci. 2008 23 361 367
112. J. S. Friedberg et al., Phase II trial of pleural photodynamic therapy and surgery for patients with non-small-cell lung cancer with pleural spread J. Clin. Oncol. 2004 22 2192 2201
113. S. M. Hahn et al., A phase II trial of intraperitoneal photodynamic therapy for patients with peritoneal carcinomatosis and sarcomatosis Clin. Cancer Res. 2006 12 2517 2525
114. K. L. Molpus et al., Intraperitoneal photodynamic therapy of human epithelial ovarian carcinomatosis in a xenograft murine model Cancer Res. 1996 56 1075 1082
115. M. A. Biel Photodynamic Therapy Treatment of Early Oral and Laryngeal Cancers Photochem. Photobiol. 2007 83 1063 1068
116. V. C. K. Lo et al., The benefits of photodynamic therapy on vertebral bone are maintained and enhanced by combination treatment with bisphosphonates and radiation therapy J. Orthop. Res. 2013 31 1398 1405
117. M. Mitsunaga et al., Cancer cell-selective in vivo near infrared photoimmunotherapy targeting specific membrane molecules Nat. Med. 2011 17 1685 1691
118. T. L. Doane C.-H. Chuang A. Chomas C. Burda Photophysics of silicon phthalocyanines in aqueous media Chem. - Eur. J. Chem. Phys. 2013 14 321 330
119. J. D. Miller et al., Photodynamic therapy with the phthalocyanine photosensitizer Pc 4: the case experience with preclinical mechanistic and early clinical-translational studies Toxicol. Appl. Pharmacol. 2007 224 290 299
120. M. B. Vrouenraets et al., Targeting of Aluminum (III) Phthalocyanine Tetrasulfonate by Use of Internalizing Monoclonal Antibodies Improved Efficacy in Photodynamic Therapy Cancer Res. 2001 61 1970 1975
121. M. B. Vrouenraets et al., Comparison of aluminium (III) phthalocyanine tetrasulfonate- and meta-tetrahydroxyphenylchlorin-monoclonal antibody conjugates for their efficacy in photodynamic therapy in vitro Int. J. Cancer 2002 98 793 798
122. D. Mew C. K. Wat G. H. Towers J. G. Levy Photoimmunotherapy: treatment of animal tumors with tumor-specific monoclonal antibody-hematoporphyrin conjugates J. Immunol. 1983 130 1473 1477
123. W. Stummer et al., Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial Lancet Oncol. 2006 7 392 401
124. I. Rizvi et al., Photoimmunotherapy and irradiance modulation reduce chemotherapy cycles and toxicity in a murine model for ovarian carcinomatosis: perspective and results Isr. J. Chem. 2012 52 776 787
125. K. Meirelles et al., Human ovarian cancer stem/progenitor cells are stimulated by doxorubicin but inhibited by Mullerian inhibiting substance Proc. Natl. Acad. Sci. U. S. A. 2012 109 2358 2363